Epigral

{
  "main_header": {
    "sid": 1003523,
    "name": "Epigral",
    "stock_name": "Epigral",
    "full_name": "Epigral Ltd",
    "name_url": "stocks-analysis/epigral",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,237.10",
    "chg": 6.5,
    "chgp": "0.53%",
    "dir": 1,
    "prev_price": "1,230.60",
    "mcapval": "5,337.01 Cr",
    "mcap": "Small Cap",
    "scripcode": 543332,
    "symbol": "EPIGRAL",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "sector_id": 74,
    "indexname": "India SENSEX",
    "isin": "INE071N01016",
    "curr_date": "Sep 03, 01:30 PM",
    "curr_time": "13:48 PM",
    "last_traded_at": "Sep 03, 01:30 PM IST",
    "bse_nse_vol": "26.41 k",
    "exc_status": "Active",
    "traded_date": "Sep 03, 2026",
    "traded_date_str": "2026 09 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/epigral-1003523-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Epigral Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-by-marketsmojo-4174891",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EpigralLtd_mojoScore_4174891.png",
        "date": "2026-08-30 10:10:14",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 August 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Epigral Ltd Valuation Shifts: From Attractive to Fair Amid Specialty Chemicals Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-valuation-shifts-from-attractive-to-fair-amid-specialty-chemicals-sector-dynamics-4168269",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EpigralLtd_valuationdot_4168269.png",
        "date": "2026-08-25 08:02:05",
        "description": "Epigral Ltd, a small-cap player in the specialty chemicals sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid a backdrop of mixed financial metrics and sector-wide valuation disparities. Investors are now reassessing the company’s price attractiveness relative to its historical averages and peer group, prompting a deeper analysis of its price-to-earnings (P/E) and price-to-book value (P/BV) ratios alongside operational returns and market performance."
      },
      {
        "title": "Epigral Ltd Shows Mixed Technical Signals Amid Mild Recovery",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-shows-mixed-technical-signals-amid-mild-recovery-4163410",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EpigralLtd_technicaldot_4163410.png",
        "date": "2026-08-21 08:04:15",
        "description": "Epigral Ltd, a specialty chemicals small-cap, has exhibited a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish trend. Despite a recent day gain of 3.88%, the stock’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others maintain a bearish outlook. This article analyses the latest technical parameters, including MACD, RSI, moving averages, and other momentum indicators, to provide a comprehensive view of Epigral’s current market positioning."
      },
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-4160953",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EpigralLtd_mojoScore_4160953.png",
        "date": "2026-08-19 10:10:58",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 August 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Epigral Ltd Technical Momentum Shifts Amid Bearish Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-technical-momentum-shifts-amid-bearish-sentiment-4160469",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EpigralLtd_technicaldot_4160469.png",
        "date": "2026-08-19 08:05:12",
        "description": "Epigral Ltd, a specialty chemicals small-cap, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend despite some mildly bullish weekly signals. The stock’s recent price action and technical parameters suggest caution for investors as the company navigates a challenging market environment."
      },
      {
        "title": "Epigral Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-technical-momentum-shifts-amid-mixed-market-signals-4158908",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EpigralLtd_technicaldot_4158908.png",
        "date": "2026-08-18 08:07:35",
        "description": "Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day change of 0.22% to close at ₹1,100.80, the stock’s technical indicators reveal a complex interplay of bullish and bearish signals, reflecting cautious investor sentiment amid broader market volatility."
      },
      {
        "title": "Epigral Ltd Technical Momentum Shifts Amid Bearish Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-technical-momentum-shifts-amid-bearish-sentiment-4157177",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EpigralLtd_technicaldot_4157177.png",
        "date": "2026-08-17 08:03:39",
        "description": "Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest recovery over the past month, the stock’s overall trajectory remains under pressure, reflecting challenges in sustaining upward momentum amid broader market dynamics."
      },
      {
        "title": "Epigral Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-by-marketsmojo-4142881",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EpigralLtd_mojoScore_4142881.png",
        "date": "2026-08-08 10:10:16",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 August 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Epigral Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-technical-momentum-shifts-amid-mixed-market-signals-4135381",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EpigralLtd_technicaldot_4135381.png",
        "date": "2026-08-04 08:10:22",
        "description": "Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish trend. Despite a recent day gain of 2.59%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, reflecting cautious investor sentiment amid broader market challenges."
      }
    ],
    "total": 646,
    "sid": "1003523",
    "stock_news_url": "https://www.marketsmojo.com/news/epigral-1003523"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Epigral Ltd has declared <strong>50%</strong> dividend, ex-date: 01 Jun 26",
          "dt": "2026-06-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Epigral Ltd is Rated Sell by MarketsMOJO

2026-08-30 10:10:14

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Epigral Ltd Valuation Shifts: From Attractive to Fair Amid Specialty Chemicals Sector Dynamics

2026-08-25 08:02:05

Epigral Ltd, a small-cap player in the specialty chemicals sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change reflects evolving market perceptions amid a backdrop of mixed financial metrics and sector-wide valuation disparities. Investors are now reassessing the company’s price attractiveness relative to its historical averages and peer group, prompting a deeper analysis of its price-to-earnings (P/E) and price-to-book value (P/BV) ratios alongside operational returns and market performance.

Read full news article

Epigral Ltd Shows Mixed Technical Signals Amid Mild Recovery

2026-08-21 08:04:15

Epigral Ltd, a specialty chemicals small-cap, has exhibited a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish trend. Despite a recent day gain of 3.88%, the stock’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others maintain a bearish outlook. This article analyses the latest technical parameters, including MACD, RSI, moving averages, and other momentum indicators, to provide a comprehensive view of Epigral’s current market positioning.

Read full news article

Epigral Ltd is Rated Sell

2026-08-19 10:10:58

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Epigral Ltd Technical Momentum Shifts Amid Bearish Sentiment

2026-08-19 08:05:12

Epigral Ltd, a specialty chemicals small-cap, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend despite some mildly bullish weekly signals. The stock’s recent price action and technical parameters suggest caution for investors as the company navigates a challenging market environment.

Read full news article

Epigral Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-08-18 08:07:35

Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day change of 0.22% to close at ₹1,100.80, the stock’s technical indicators reveal a complex interplay of bullish and bearish signals, reflecting cautious investor sentiment amid broader market volatility.

Read full news article

Epigral Ltd Technical Momentum Shifts Amid Bearish Sentiment

2026-08-17 08:03:39

Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest recovery over the past month, the stock’s overall trajectory remains under pressure, reflecting challenges in sustaining upward momentum amid broader market dynamics.

Read full news article

Epigral Ltd is Rated Sell by MarketsMOJO

2026-08-08 10:10:16

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Epigral Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-08-04 08:10:22

Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish trend. Despite a recent day gain of 2.59%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, reflecting cautious investor sentiment amid broader market challenges.

Read full news article

View All News